申请人:Barnes-Jewish Hospital
公开号:US20040203072A1
公开(公告)日:2004-10-14
The invention relates to methods for determining the progression of cartilage degeneration diseases, such as osteoarthrits and rheumatoid arthritis, by quantitating collagen synthesis and degradation markers in patient samples. One can determine whether a cartilage degeneration condition is progressing, regressing, or remaining stable by quantitating collagen synthesis and degradation markers in patient samples and comparing the value obtained to a reference value. When a joint affected by cartilage degeneration in question expresses collagen synthesis and degradation markers, a change in this value is indicative of a change in the progression of the cartilage degeneration condition. The methods and apparatus of the invention allow accurate determination of the therapeutic effects certain cartilage degeneration drug treatments, including osteoarthritis and rheumatoid arthritis drug treatments, so are also useful for pharmaceutical efficacy studies in mammals.
本发明涉及通过量化患者样本中的胶原合成和降解标记物来确定软骨退化疾病(如骨关节炎和类风湿性关节炎)进展情况的方法。通过量化患者样本中的胶原合成和降解标记物,并将所得值与参考值进行比较,可以确定软骨退行性疾病是在发展、退步还是保持稳定。当受软骨退化影响的关节表达胶原合成和降解标记物时,该值的变化表明软骨退化状况的进展发生了变化。本发明的方法和装置可以准确测定某些软骨退化药物治疗的疗效,包括骨关节炎和类风湿性关节炎药物治疗的疗效,因此也适用于哺乳动物的药效研究。